Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN85,285,282,02
Msft0,84
Nokia3,213,22-0,62
IBM-0,82
Daimler AG50,5150,541,42
PFE-0,54
14.12.2019 2:00:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.12.2019 22:00:00
West Pharm Svc (WST, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
146,45 -0,01 -0,01 279 933
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.12.2019
Popis společnosti
Obecné informace
Název společnostiWest Pharmaceutical Services Inc.
TickerWST
Kmenové akcie:Ordinary Shares
RICWST
ISINUS9553061055
Poslední známé roční výsledky31.12.2018
Poslední známé čtvrtletní výsledky30.09.2019
Počet zaměstnanců k 31.12.2018 7 700
Akcie v oběhu k 30.09.2019 74 000 000
Počet akcionářů k 31.12.2018 805
MěnaUSD
Konstituent indexůS&P 400 Mid Cap
Kontaktní informace
Ulice530 HERMAN O WEST DR
MěstoEXTON
PSČ19341-1147
ZeměUnited States
Kontatní osobaQuintin Lai
Funkce kontaktní osobyVice President - Corporate Development, Strategy and Investor Relations
Telefon16 105 942 900
Fax18003459800
Kontatní telefon16 105 943 318

Business Summary: West Pharmaceutical Services, Inc. is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company's products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. The Company's segments include Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment develops commercial and operational strategies across its global network, with specific emphasis on product offerings to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as an integrated business focused on the design, manufacture and automated assembly of various devices, primarily for pharmaceutical, diagnostic and medical device customers.
Financial Summary: BRIEF: For the nine months ended 30 September 2019, West Pharmaceutical Services Inc. revenues increased 6% to $1.37B. Net income before extraordinary items increased 15% to $177.8M. Revenues reflect Proprietary Products segment increase of 5% to $1.05B, Contract-Manufactured Products segment increase of 9% to $323.6M. Net income benefited from Proprietary Products segment income increase of 18% to $238.7M.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution - NEC
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICSMedical Laboratories
SICSurgical And Medical Instruments
SICMedical Laboratories



  • Poslední aktualizace: 15.12.2019
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman of the BoardPatrick Zenner7201.07.201501.07.2015
President, Chief Executive Officer, DirectorEric Green4917.12.201524.04.2015
Chief Financial Officer, Senior Vice President, Principal Accounting Officer, TreasurerBernard Birkett5007.10.201921.06.2018
Chief Human Resource Officer, Senior Vice PresidentAnnette Favorite5405.10.201505.10.2015
Senior Vice President, General Counsel, Corporate SecretaryGeorge Miller6419.11.201519.11.2015
Senior Vice President and Chief Digital and Transformation OfficerSilji Abraham4726.02.201826.02.2018
Senior Vice President and Chief Commercial OfficerKaren Flynn5612.01.2016
Senior Vice President - Global Operations and Supply ChainDavid Montecalvo5326.09.201626.09.2016
Senior Vice President of Global Market Units and Commercial SolutionsCindy Reiss-Clark-31.12.201931.12.2019
Senior Vice President of Commercial Products and Emerging MarketsChristopher Ryan5531.12.2019